Geschreven door studenten die geslaagd zijn Direct beschikbaar na je betaling Online lezen of als PDF Verkeerd document? Gratis ruilen 4,6 TrustPilot
logo-home
Overig

NR503 FINAL EXAM STUDY GUIDE VERSION 1 / NR 503 FINAL EXAM STUDY GUIDE VERSION 1 (NEWEST 2021) | CHAMBERLAIN COLLEGE OF NURSING

Beoordeling
-
Verkocht
-
Pagina's
15
Geüpload op
26-08-2021
Geschreven in
2021/2022

NR503 FINAL EXAM STUDY GUIDE VERSION 1 / NR 503 FINAL EXAM STUDY GUIDE VERSION 1 (NEWEST 2021) | CHAMBERLAIN COLLEGE OF NURSING

Instelling
Vak

Voorbeeld van de inhoud

NR 503 - Study Guide for Final Exam

1. Objectives of epidemiology.2-7
Step 1. Understanding the etiology or cause of a disease (risk factors)
Step 2. Finding out the extent that a disease or health problem affects a
community or population.
Step 3. Determine the natural history or prognosis
Step 4. Evaluate existing and newly developed preventative therapeutic
measures and modes of healthcare delivery
Step 5. Provide the foundation for developing public policy relating to
environmental problems, genetic issues, and other considerations regarding
disease prevention and health promotion.
2. Define, compare, calculate, and interpret Measures of Morbidity .41.58
a. Incidence rate.41.51
(# of NEW cases of a disease occurring in the population during a
specified period of time / # of persons who are at risk of developing
the disease during that period of time) x 1000 = Incidence rate per
1,000
: the NEW cases of a disease over a period of time.
b. Attack rate.46
- special form of cumulative incidence
- Used for diseases of short observation time period
- Not a true rate because the time dimension is often uncertain (food
borne outbreaks)
= (# of new cases among population during period / population at risk
at beginning of period) x 100 (expressed as %)
c. Prevalence.46
: the EXISTING cases of a disease over a period of time.
(# of cases of a disease present in the population at a specified time / #
of persons in the population at that specified time) x 1,000 =
Prevalence per 1,000
3. Understand why incidence data are important for measuring risk.
 Measures risk (probability of developing disease)
 Useful for investigating determinants of disease (not survival)
 To investigate causes of disease
 Need to know population ‘at risk’ or ‘person-time’ at risk
4. Define, compare, calculate, and interpret Measures of Mortality
a. Cause-specific mortality rate.64.65
=(Total number of deaths due to x cause / total population at mid
year) x 1,000

, =(No.of deaths from leukemia in one year in children younger than 10
years of age / No.of children in the population younger than 10 years
of age at midyear) x 1,000
b. Annual mortality rate .64
-annual death rate, or mortality rate from all causes.
(total # of deaths from all causes in 1 year / total population at mid
year ) x 1,000
c. Case-fatality.65
--what percentage of people who have a certain disease die within a
certain time after their disease was diagnosed?
=(# of deaths due to a certain disease/total # suffering from that
disease) x 100 %
-Measure of the severity of the disease
-As therapy improves, case-fatality would be expected to decline.
d. Proportionate mortality. This is Not a rate. 66
-the proportionate mortality from cardiovascular disease in the U.S. in
2010 (percent, %)
-of all deaths in the US, what proportion was caused by cardiovascular
disease?
=( # of deaths from cardiovascular diseases in US in 2010 / total
deaths in the US in 2010) x 100

5. Assess the Validity.89 and Reliability105.110 of Diagnostic and Screening
Tests
a. Define, compare and calculate measures of validity, including
sensitivity and specificity.
-Validity of test: its ability to distinguish between who has a disease
and who does not.
-Sensitivity of test is defined as the ability of the test to identify
correctly those who have the disease.
-Specificity of test is defined as the ability of the test to identify
correctly those who do not have the disease.

Have a Disease Do not have
Disease
Positive True Positive False Positive Positive
(TP) (FP) predictive value
Have the Do not have the =
disease disease (TP/TP+FP)x100
And test But test =(a/a+b)x100
positive positive

Geschreven voor

Instelling
Vak

Documentinformatie

Geüpload op
26 augustus 2021
Aantal pagina's
15
Geschreven in
2021/2022
Type
OVERIG
Persoon
Onbekend

Onderwerpen

$18.99
Krijg toegang tot het volledige document:

Verkeerd document? Gratis ruilen Binnen 14 dagen na aankoop en voor het downloaden kun je een ander document kiezen. Je kunt het bedrag gewoon opnieuw besteden.
Geschreven door studenten die geslaagd zijn
Direct beschikbaar na je betaling
Online lezen of als PDF

Maak kennis met de verkoper

Seller avatar
De reputatie van een verkoper is gebaseerd op het aantal documenten dat iemand tegen betaling verkocht heeft en de beoordelingen die voor die items ontvangen zijn. Er zijn drie niveau’s te onderscheiden: brons, zilver en goud. Hoe beter de reputatie, hoe meer de kwaliteit van zijn of haar werk te vertrouwen is.
NURSINGWORLD RASMUSSEN COLLEGE
Volgen Je moet ingelogd zijn om studenten of vakken te kunnen volgen
Verkocht
24
Lid sinds
5 jaar
Aantal volgers
22
Documenten
43
Laatst verkocht
3 jaar geleden

2.7

3 beoordelingen

5
1
4
0
3
0
2
1
1
1

Recent door jou bekeken

Waarom studenten kiezen voor Stuvia

Gemaakt door medestudenten, geverifieerd door reviews

Kwaliteit die je kunt vertrouwen: geschreven door studenten die slaagden en beoordeeld door anderen die dit document gebruikten.

Niet tevreden? Kies een ander document

Geen zorgen! Je kunt voor hetzelfde geld direct een ander document kiezen dat beter past bij wat je zoekt.

Betaal zoals je wilt, start meteen met leren

Geen abonnement, geen verplichtingen. Betaal zoals je gewend bent via iDeal of creditcard en download je PDF-document meteen.

Student with book image

“Gekocht, gedownload en geslaagd. Zo makkelijk kan het dus zijn.”

Alisha Student

Bezig met je bronvermelding?

Maak nauwkeurige citaten in APA, MLA en Harvard met onze gratis bronnengenerator.

Bezig met je bronvermelding?

Veelgestelde vragen